Investigator Grants Clause Samples
The Investigator Grants clause defines the rights and permissions granted by the investigator to the sponsor or institution regarding intellectual property, data, or materials developed during a research project. Typically, this clause outlines the scope of the grant, such as whether it is exclusive or non-exclusive, and may specify the permitted uses, such as for research, commercialization, or publication. Its core function is to clarify ownership and usage rights, thereby preventing future disputes over the results or inventions arising from the investigator's work.
Investigator Grants. (a) Twenty percent (20%) of the estimated total of the grant payments of the study, totaling $[****], will be invoiced upon commencement of services. Prepayment for Investigator Grants (to be drawn down once paid and replenished once 75% depleted). This process to continue until the end of the study.
(b) inVentiv Health Clinical will submit invoices in advance for estimated amounts to be paid to investigators during the next quarter to ensure that adequate funds are available to pay investigator grants
(c) inVentiv Health Clinical will not make payments to investigators without having sufficient funds available in advance.
(d) Any unused funds will be returned within ninety (90) days from the date of the final reconciliation
Investigator Grants. (a) [****] percent ([****]%) of the estimated grant payments for the study, equaling $[****], will be invoiced upon commencement of services. These funds will be drawn down as the Investigator Grants are paid and the full [****]% will be replenished once the amounts held are [****]% depleted). This process to continue until the end of the study.
(b) inVentiv Health Clinical will submit invoices for the amounts paid to investigators during the previous month. Any amount exceeding the estimate investigator grant payments will be pre-approved by the Company.
(c) inVentiv Health Clinical will not make payments to investigators without having sufficient funds available in advance.
(d) Any unused funds will be returned within ninety (90) days from the date of the final reconciliation
Investigator Grants. Twenty percent (20%) of the estimated total of the grant payments of the study, totaling $ [****] , will be invoiced upon commencement of services. Prepayment for Investigator Grants (to be drawn down once paid and replenished once 75% depleted). This process to continue until the end of the study.
Investigator Grants. 4.3.1. To the extent agreed to in a Work Order, Syneos Health is responsible to administer payments to Investigators on behalf of Sponsor according to the applicable Clinical Trial Agreement and Work Order (“Investigator Grants”). Investigator Grants shall be paid in advance of Syneos Health’s expectation to pay the Investigator, and Sponsor shall be responsible for any adverse action taken by an Investigator as a result of failure to pay Investigator Grants and other costs due and payable in a timely manner. Each Clinical Trial Agreement will contain a statement to this effect.
4.3.2. Initial payment of Investigator Grants shall be set forth in the Work Order, as applicable. As the Study progresses, such initial grant payment will be applied to Investigator fees and other approved fees. Syneos Health will invoice Sponsor quarterly, based on estimated Investigator payment accruals anticipated for the applicable Study in the following quarter, less any previously unused funds from previous requests.